Study details
Enrolling now
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
C5 Biomedical
NCT IDNCT06674980ClinicalTrials.gov data as of Apr 2026
Target enrollment
177
Study length
about 2.1 years
Ages
18+
Locations
1 site in LA
About this study
Researchers are testing whether human placental membrane products, used with standard care, are more effective than standard care alone for nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). The trial will last 763 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.AM/Double - DFU
- 2.AM/Double - VLU
- 3.AM/Single - DFU
- +3 more
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low14%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Adverse Events, Change in pain in target ulcer, Determine improvement in quality of life
Body systems
Dermatology, Endocrinology, Cardiology / Heart